hexamethonium has been researched along with u 0126 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kanda, Y; Watanabe, Y | 1 |
Chang, YT; Chen, CC; Chen, WH; Chen, YH; Cheng, YF; Shih, HC; Shyu, BC | 1 |
2 other study(ies) available for hexamethonium and u 0126
Article | Year |
---|---|
Nicotine-induced vascular endothelial growth factor release via the EGFR-ERK pathway in rat vascular smooth muscle cells.
Topics: Animals; Blotting, Western; Butadienes; Enzyme Inhibitors; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Hexamethonium; Muscle, Smooth, Vascular; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nitriles; Phosphorylation; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Tyrphostins; Vascular Endothelial Growth Factor A | 2007 |
Cardioprotection induced in a mouse model of neuropathic pain via anterior nucleus of paraventricular thalamus.
Topics: Animals; Butadienes; Chronic Pain; Disease Models, Animal; Enzyme Inhibitors; Ganglionic Blockers; Heart Rate; Hexamethonium; Lidocaine; Male; Mice, Inbred C57BL; Midline Thalamic Nuclei; Myocardial Infarction; Myocardial Reperfusion Injury; Neuralgia; Nitriles; Optogenetics | 2017 |